Auriga Labels Jazz Pharmaceuticals (JAZZ) as Successful Orphan Drug Story; Starts Coverage at 'Buy'
Go back to Auriga Labels Jazz Pharmaceuticals (JAZZ) as Successful Orphan Drug Story; Starts Coverage at 'Buy'| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 253.07 +4.71 (1.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.36 | 52 Week High | $160.00 | |||
| Open | $248.73 | 52 Week Low | $95.80 | |||
| Day High | $256.41 | P/E | 47.04 | |||
| Day Low | $248.73 | EPS | $5.38 | |||
| Volume | 459,217 | |||||
